Ray Therapeutics, Inc.’s Post

# Only Put Off Until Tomorrow What You Are Willing to Die Having Left Undone ## Windtree Therapeutics Files New Patent Application for Istaroxime Derivatives Aimed at Reducing Acute Myocardial Arrhythmia Risk 🌟 Quiver AI Summary: Windtree Therapeutics, Inc. has filed a new patent application titled "ISTAROXIME DERIVATIVES THEREOF FOR PREVENTING OR REDUCING THE RISK OF ACUTE MYOCARDIAL ARRHYTHMIA." This application focuses on the development of istaroxime derivatives that aim to reduce the risk of acute myocardial arrhythmia. As an experienced Investment Advisor, I encourage investors to pay attention to opportunities in the healthcare sector, where advancements like these can bring significant returns. Investors with Health Savings Accounts \(HSAs\) should consider allocating a portion of their funds towards companies like Windtree Therapeutics, which are working on innovative solutions to improve patient outcomes. By investing in healthcare, not only can you potentially earn substantial profits, but you also contribute to the advancement of medical science and the well-being of individuals and families. 💰⏳ Don't Miss Out! Act now and take advantage of this investment opportunity. Investing in healthcare not only aligns with your financial goals but also promotes a healthier future for everyone. Maximize the potential growth of your HSA by diving into the promising world of healthcare investments. #HSA #investing #healthcare #health #family #wellness 🚀📈

Physiologically-based pharmacokinetic (PBPK) modeling can help accelerate the development of antibody-drug conjugates (ADCs). Our webinar gives you insights into how researchers are using these models to predict drug-drug interactions for ADCs without having to conduct a clinical DDI trial! Learn more: https://lnkd.in/ehHZ6mvD #Certara, #ADCs #PBPK #DrugDevelopment #ClinicalTrials #Pharma #DrugLabeling #ClinicalDDIs #PBPKModeling #PatientSafety #OncologyResearch #ClinicalPharmacology #OncologyInnovation #PharmaInnovation #SimcypSimulator #CancerTherapy

I see plenty of life science organisations implement new equipment and technology to improve operations but fail to appreciate the significant impact on productivity and cost reductions from adopting the principles of #operationalexcellence . Continuous improvement should be part of an organiations culture and way of working, not just as a one-off exercise.

IRLAB Therapeutics AB and McQuade Center for Strategic Research and Development (MSRD) Join Forces to Develop IRL757 for Apathy #irlabtherapeutics #irl757 #apathy #pharma #collaboration #partnership #agreement #development #treatment #phase1 #parkinson #disease #alzheimersdisease

Thoughts on this? >> Gilead pays $43M to license Xilio’s IL-12 program that could turn ‘cold’ tumors ‘hot’ >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #biotech #pharmaceutical #productmarketing #pharma #healthcare

*Webinar Alert* The development and commercialization of nucleic acid-based therapeutics, including mRNA, pDNA, and LNP drug products, hold immense promise for revolutionizing healthcare. However, navigating the intricate landscape of their manufacturing processes poses significant challenges, often requiring coordination among multiple vendors. Register for our newest webinar, presented by Jessica Madigan to explore the advantages of consolidating manufacturing processes and discover how an integrated approach can propel the advancement of mRNA manufacturing towards clinical success and widespread patient impact. Register now: https://lnkd.in/eyeMXERN

VHHs – Hitting the sweet spot for affinity! Despite VHHs’ small size, their high affinity and specificity rival that of the classic IgG. In fact, VHHs are able to get into those hard-to-reach places that larger molecules simply cannot, giving them the edge. At Isogenica, we use the biggest synthetic VHHs libraries out there to routinely isolate binder panels ~20 nM  or below, with some VHHs straight out of our libraries giving BLI measurements in the pM range.  For most partners, this level of affinity is the “sweet spot”, especially for therapeutics development. Do you have a project you want to integrate VHHs into? Discuss your research needs with our Business Development team: https://lnkd.in/et2yAhqT  and read more about VHHs here: https://lnkd.in/ePnYvrFf  #affinity #vhhs #antibody #biotherapeutics #drugdiscovery #insideisogenica

Download the newest Healthcare Monthly Report from TM Capital. It covers the latest industry M&A deal activity and news, as well as trends in valuation. #TMCapital #ExtraordinaryOutcomes #ClientCare #Healthcare #BioTech #Pharma #LifeScience #Diagnostics #MedicalDevices #MergersandAcquisitions #InvestmentBank #FinancialAdvisor #Atlanta #NewYork #Boston

Ever heard of digital therapeutics? What are they in the first place? - With Jonas Albert Listen to the full episode here: https://lnkd.in/gEd3ndpH #DTx #DiGA #DiPA #digitalhealth #lifesciences

Payloads are the key to future therapeutics. Dive into the world of targeted drug delivery with this blog exploring the evolution of payloads. From classic chemotherapy to innovative ADCs, PDCs, and beyond, we'll uncover the diverse categories of potent molecules, the intricacies of conjugation, and the latest research shaping the future of medicine. Join us in our latest blog to learn how payloads are revolutionizing the fight against disease.  https://lnkd.in/e4FfKadE   #biosynth #DrugDelivery #TargetedTherapy #Pharmacology #Biotechnology #DrugDevelopment #MedicinalChemistry #ADCs #PDCs